Zhangzhou Narcissus Pharmaceutical Co.,Ltd. announced that it will issue common shares in a round of funding on October 25, 2022. The transaction will include participation from returning investor Fujian Qingshan Paper Industry Co.,Ltd. The transaction has been approved in the 1st Extraordinary Shareholders Meeting of 2022.